Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Serum Micro RNA-371 in Detecting Active Germ Cell Tumors in Patients With Suspected Regional Disease - (MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial)

NCT06060873 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT06060873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06060873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Serum Micro RNA-371 in Detecting Active Germ Cell Tumors in Patients With Suspected Regional Disease - (MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial)
Lead sponsor
University of Southern California
Phase
Observational
Overall status
Recruiting
Start date
June 8, 2023
Completion date
December 8, 2028
Enrollment
418 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malignant testicular germ cell tumor